FdaApplication
NDA 021285
Identifiers
- fda_app_no: NDA021285
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2001-05-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRILEPTAL | OXCARBAZEPINE | 300MG/5ML | SUSPENSION;ORAL |
1 product